Panitumumab (Zr-89 labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Panitumumab (Zr-89 labeled), covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma [EARLY_Phase 1]